Source - RNS
RNS Number : 2097L
Circassia Pharmaceuticals Plc
30 September 2016
 

For immediate release

 

Circassia Pharmaceuticals plc

 

Total Voting Rights Update

 

 

 

30th September 2016

 

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 284,889,171 ordinary shares of 0.08p each in issue, each with equal voting rights.  No shares are held in treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure and Transparency Rules.

 

-Ends-

 

For further information, please contact:

 

Circassia Pharmaceuticals plc

Julien Cotta, Company Secretary

 

+44 (0) 1865 405560

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREAENNAEKKEFF

Related Charts

Circassia Pharmaceuticals (CIR)

-1.25p (-1.38%)
delayed 18:15PM